Historical Pathogen-Driven Selection May Contribute to Contemporary Ethnic Difference in Bladder Cancer Susceptibility
Bladder Cancer · 01.09.2023 · 9 (3) · 211-216
DOI: 10.3233/blc-230010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 01.08.2023. Verfasst von Xiang-Yu Meng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Hubei Minzu University, Enshi, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: The rationale for ethnic differences in bladder cancer (BCa) susceptibility is an important open question. In this study, we raised the hypothesis that the APOBEC3-rs1014971 variant associated with BCa risk and APOBEC-mutagenesis probably contribute to ethnic differences. METHODS: We calculated the ethnicity-stratified 5-year age-adjusted incidence rates of BCa using the US SEER database. We performed somatic mutational-signature analyses and compared the APOBEC-related mutational contribution across BCa tumors in patients of different ethnicities. We analyzed the allele frequency distribution of APOBEC3-related rs1014971 in contemporary populations of different ethnicities and in ancient human genomes. We also analyzed the natural selection profiles and ages of the investigated SNPs. RESULTS: We validated the ethnic difference in BCa risk using US SEER data, revealing Caucasians to be at >2-fold greater risk than Asians / Pacific islanders. In contemporary populations, we observed a coherent ethnic distribution in terms not only of the allele frequency of APOBEC3-related rs1014971, but also the mutational contribution of APOBEC-mediated mutagenesis in BCa tumors. Population genetics and ancient genome analyses further suggested that the diverse ethnic distribution of rs1014971 could be rooted in human evolution. CONCLUSIONS: It is possible that APOBEC3-related rs1014971 is involved in the different BCa incidence across ethnic groups, and this difference is potentially derived from human evolution. Our findings suggested an evolutionary link between contemporary population-level variations in malignancy susceptibility and pathogen-driven selection in the past, not unlike previously reported cases of certain autoimmune and metabolic disorders.
Autor:innen und Institutionen
- Health Science Center, Hubei Minzu University, Enshi, China.
- Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan, China.
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
- Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Meng, X. Y., Wang, Q. L., Shi, M. J., & Zhang, H. Y. (2023). Historical Pathogen-Driven Selection May Contribute to Contemporary Ethnic Difference in Bladder Cancer Susceptibility. Bladder Cancer, 9(3), 211-216. https://doi.org/10.3233/blc-230010
Vancouver
Meng XY, Wang QL, Shi MJ, Zhang HY. Historical Pathogen-Driven Selection May Contribute to Contemporary Ethnic Difference in Bladder Cancer Susceptibility. Bladder Cancer. 2023;9(3):211-216. doi:10.3233/blc-230010
BibTeX
@article{Meng2023,
author = {Meng, Xiang-Yu and Wang, Qiao-Li and Shi, Ming-Jun and Zhang, Hong-Yu},
title = {Historical Pathogen-Driven Selection May Contribute to Contemporary Ethnic Difference in Bladder Cancer Susceptibility},
journal = {Bladder Cancer},
year = {2023},
volume = {9},
number = {3},
pages = {211--216},
doi = {10.3233/blc-230010}
}
EUVIMED